Medical Imaging Corp.: CTS Adds New Client Hospital

LAS VEGAS, NEVADA--(Marketwired - Feb. 9, 2015) - Medical Imaging Corp. (OTCQB:MEDD)(OTC PINK:MEDD) announced today that its wholly-owned subsidiary, Custom Teleradiology Services ("CTS"), has signed a new client hospital.

CTS signed a contract with a new client hospital to provide teleradiology services. Installation and set-up are now complete and radiology reading services have now begun. Coverage will include weekday night times as well as 24 hour coverage on weekends and holidays.

The contract specializes in emergency after hours CT service. CT's are a high paying modality that will benefit CTS. Additionally CTS will be reporting on X-ray, US and a limited number of MRI studies.

CTS is a leading supplier and solution for remote rural hospitals and helps to ensure they can provide quality service to their communities. CTS service will allow the hospital to offer its patients the ability to provide emergency care on a 24 hour 7 day a week cycle.

CTS plans to continue its growth by adding new client contracts and thus increasing radiologist reading revenue.

About MEDD

Medical Imaging Corp. ("MEDD") is engaged in providing comprehensive medical imaging services to clients in the United States and Canada through its four Diagnostic Imaging Centers, and its' Teleradiology Services. For more information, please visit www.medimagingcorp.com.

This news release includes forward-looking statements that reflect Medical Imaging Corp.'s current expectations about its future results, performance, prospects and opportunities. Medical Imaging Corp. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to Medical Imaging Corp. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2015 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.